Ph.D., CEO, Abreos Biosciences
Dr. Messmer is a scientist and entrepreneur and is currently the CEO of Abreos Biosciences, a precision medicine company he founded in 2013. Prior to that, he was research faculty at the UCSD Moores Cancer Center, where his work spanned numerous disciplines including biotechnology, nanotechnology, molecular biology, immunology, and cancer biology. He received his PhD from Rockefeller University in 2000 where he worked in the lab of Joshua Lederberg, the “father” of molecular biology.
Abreos Biosciences is a precision medicine company in San Diego, CA developing laboratory-based and near-patient tests for precision dosing of biologic drugs. Abreos has cultivated a diverse portfolio of Veritope™ tests that allow for direct monitoring of blood concentrations of monoclonal antibody drugs (novel or biosimilar).